NCT01638650View on ClinicalTrials.gov

A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
HIV Infections
Interventions
DRUG

Nucleoside Reverse Transcriptase Inhibitor (NRTIs)

in accordance with current clinical HIV treatment guidelines

DRUG

ritonavir

100 mg bid orally, Days 1-14

DRUG

saquinavir [Invirase]

500 mg bid orally Days 1-7, 1000 mg bid orally Days 8-14

Trial Locations (1)

SW10 9NH

London

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01638650 - A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients | Biotech Hunter | Biotech Hunter